Search research articles
Contact Us
Filters
Showing results (131-140 of 142) with videos related to
Page
of 15
Sort By:
Scientific Reports
|
September 14, 2022
Effects of luseogliflozin and voglibose on high-risk lipid profiles and inflammatory markers in diabetes patients with heart failure
Kentaro Ejiri, Toru Miyoshi, Hajime Kihara, et al.
Journal of the American Heart Association
|
August 18, 2020
Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus
Kentaro Ejiri, Toru Miyoshi, Hajime Kihara, et al.
International Journal of Cardiology
|
March 8, 2011
Pro-apoptotic effects of imatinib on PDGF-stimulated pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension
Kazufumi Nakamura, Satoshi Akagi, Aiko Ogawa, et al.
ESC Heart Failure
|
March 10, 2022
Effects of luseogliflozin on estimated plasma volume in patients with heart failure with preserved ejection fraction
Mitsutaka Nakashima, Toru Miyoshi, Kentaro Ejiri, et al.
Journal of Cardiology
|
April 5, 2021
Pathological and clinical effects of interleukin-6 on human myocarditis
Naofumi Amioka, Kazufumi Nakamura, Tomonari Kimura, et al.
Stem Cell Research & Therapy
|
September 27, 2025
Specific induction of right ventricular-like cardiomyocytes from human pluripotent stem cells
Yukihiro Saito, Kazufumi Nakamura, Yuki Katanosaka, et al.
BMJ Open
|
March 12, 2026
Protocol for an open-label, randomised, controlled trial to evaluate the efficacy and safety of sotatercept add-on therapy compared with pulmonary vasodilator-based standard of care for pulmonary vasodilator-resistant pulmonary arterial hypertension associated with unrepaired congenital shunts (atrial septal defect, ventricular septal defect or patent ductus arteriosus), including Eisenmenger syndrome: the SuMILE trial
Keimei Yoshida, Kazuya Hosokawa, Takahiro Hiraide, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
June 29, 2022
Overview of the 86<sup>th</sup> Annual Scientific Meeting of the Japanese Circulation Society - Cardiology Spreading Its Wings
Kazufumi Nakamura, Toru Miyoshi, Satoshi Akagi, et al.
Thrombosis Journal
|
April 16, 2025
Anticoagulant effects of edoxaban in cancer and noncancer patients with venous thromboembolism
Masashi Yoshida, Kentaro Ejiri, Naoaki Matsuo, et al.
The European Respiratory Journal
|
January 15, 2021
Serum and pulmonary uric acid in pulmonary arterial hypertension
Laurent Savale, Satoshi Akagi, Ly Tu, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 142) with videos related to
Sort By:
Page
of 15
Scientific Reports
|
September 14, 2022
Effects of luseogliflozin and voglibose on high-risk lipid profiles and inflammatory markers in diabetes patients with heart failure
Kentaro Ejiri, Toru Miyoshi, Hajime Kihara, et al.
Journal of the American Heart Association
|
August 18, 2020
Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus
Kentaro Ejiri, Toru Miyoshi, Hajime Kihara, et al.
International Journal of Cardiology
|
March 8, 2011
Pro-apoptotic effects of imatinib on PDGF-stimulated pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension
Kazufumi Nakamura, Satoshi Akagi, Aiko Ogawa, et al.
ESC Heart Failure
|
March 10, 2022
Effects of luseogliflozin on estimated plasma volume in patients with heart failure with preserved ejection fraction
Mitsutaka Nakashima, Toru Miyoshi, Kentaro Ejiri, et al.
Journal of Cardiology
|
April 5, 2021
Pathological and clinical effects of interleukin-6 on human myocarditis
Naofumi Amioka, Kazufumi Nakamura, Tomonari Kimura, et al.
Stem Cell Research & Therapy
|
September 27, 2025
Specific induction of right ventricular-like cardiomyocytes from human pluripotent stem cells
Yukihiro Saito, Kazufumi Nakamura, Yuki Katanosaka, et al.
BMJ Open
|
March 12, 2026
Protocol for an open-label, randomised, controlled trial to evaluate the efficacy and safety of sotatercept add-on therapy compared with pulmonary vasodilator-based standard of care for pulmonary vasodilator-resistant pulmonary arterial hypertension associated with unrepaired congenital shunts (atrial septal defect, ventricular septal defect or patent ductus arteriosus), including Eisenmenger syndrome: the SuMILE trial
Keimei Yoshida, Kazuya Hosokawa, Takahiro Hiraide, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
June 29, 2022
Overview of the 86<sup>th</sup> Annual Scientific Meeting of the Japanese Circulation Society - Cardiology Spreading Its Wings
Kazufumi Nakamura, Toru Miyoshi, Satoshi Akagi, et al.
Thrombosis Journal
|
April 16, 2025
Anticoagulant effects of edoxaban in cancer and noncancer patients with venous thromboembolism
Masashi Yoshida, Kentaro Ejiri, Naoaki Matsuo, et al.
The European Respiratory Journal
|
January 15, 2021
Serum and pulmonary uric acid in pulmonary arterial hypertension
Laurent Savale, Satoshi Akagi, Ly Tu, et al.
Page
of 15